Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

British Journal of Cancer
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. british journal of cancer
  3. regular article
  4. article
Thirty-five year mortality following receipt of SV40-contaminated polio vaccine during the neonatal period
Download PDF
Download PDF
  • Regular Article
  • Open access
  • Published: 30 October 2001

Thirty-five year mortality following receipt of SV40-contaminated polio vaccine during the neonatal period

  • C Carroll-Pankhurst1,
  • E A Engels2,
  • H D Strickler2,
  • J J Goedert2,
  • J Wagner3 &
  • …
  • E A Mortimer Jr3 

British Journal of Cancer volume 85, pages 1295–1297 (2001)Cite this article

  • 4895 Accesses

  • 41 Citations

  • 46 Altmetric

  • Metrics details

This article has been updated

Abstract

Early poliovirus vaccines, both inactivated and live attenuated, were inadvertently contaminated with simian virus 40 (SV40), a monkey virus known to be oncogenic for newborn hamsters. Although large epidemiologic studies have not identified an elevated cancer risk in persons who received SV40-contaminated vaccines, fragments of SV40 DNA have recently been identified in certain human tumours. We report the follow-up of a cohort of 1073 persons, unique because they received SV40-contaminated poliovirus vaccines as newborns in 1961–63. A previous report of the status of these subjects as of 1977–79 identified 15 deaths, none due to cancer. The present study utilized the National Death Index to identify deaths in the cohort for the years 1979–96. Expected deaths were calculated from Cleveland area sex-, age-, race- and year-specific mortality rates. Increased mortality from all causes was not found. 4 deaths from cancer were found compared to 3.16 expected (P= 0.77). However, 2 deaths from testicular cancer occurred, compared to 0.05 expected (P= 0.002), which may be a chance finding due to multiple comparisons. There were 2 deaths due to leukaemia, a non-significant finding, and no deaths due to tumours of the types putatively associated with SV40. Although these results are, for the most part, consistent with other negative epidemiologic investigations of risks from SV40-contaminated vaccines, further study of testicular cancer may be warranted, and it will be important to continue monitoring this cohort which is now reaching middle-age. © 2001 Cancer Research Campaign www.bjcancer.com

Similar content being viewed by others

Genetic stabilization of attenuated oral vaccines against poliovirus types 1 and 3

Article Open access 14 June 2023

Identifying early symptoms associated with a diagnosis of childhood, adolescent and young adult cancers: a population-based nested case-control study

Article Open access 14 July 2024

The diversity of CD8+ T cell dysfunction in cancer and viral infection

Article 11 April 2025

Article PDF

Change history

  • 16 November 2011

    This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication

References

  • Butel JS and Lednicky JA (1999) Review. Cell and molecular biology of Simian virus 40: implications for human infections and disease. J Natl Cancer Inst 91: 119–134

    Article  CAS  Google Scholar 

  • Carbone M, Pass HI, Rizzo P, Marinetti MR, DiMuzio M, Mew DJP, Levine AS and Procopio A (1994) Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene 9: 1781–1790

    CAS  PubMed  Google Scholar 

  • Diamandopoulos GTh (1972) Leukemia, lymphoma, and osteosarcoma induced in the Syrian golden hamster by Simian virus 40. Science 176: 173–175

    Article  CAS  Google Scholar 

  • Fraumeni JF, Stark CR, Gold E and Lepow ML (1970) Simian virus 40 in polio vaccine: follow-up of newborn recipients. Science 167: 59–60

    Article  Google Scholar 

  • Geissler E (1990) SV40 and human brain tumors. Prog Med Virol 37: 211–222

    CAS  PubMed  Google Scholar 

  • Gerber P, Hottle GA and Grubbs RE (1961) Inactivation of vacuolating virus (SV40) by formaldehyde. Proc Soc Exp Biol Med 108: 205–209

    Article  CAS  Google Scholar 

  • Hennekens CH and Buring JE (1987) Epidemiology in Medicine. Little Brown: Boston

  • Lepow ML, Warren RJ, Ingram VG, Daugherty SC and Robbins FC (1962) Sabin type 1 oral poliomyelitis vaccine: effect of dose upon response of newborn infants. Am J Dis Child 104: 67–71

    Article  CAS  Google Scholar 

  • Martini F, Iaccheri L, Lazzarin L, Carinci P, Corallini A, Gerosa M, Iuzzolino P, Barbanti-Brodano G and Tognon M (1996) SV40 region and large T antigen in human brain tumors, peripheral blood cells, and sperm fluids from healthy individuals. Cancer Research 56: 4820–4825

    CAS  PubMed  Google Scholar 

  • Martini F, Dolcetti R, Gloghini A, Iacherri L, Carbone A, Boiocchi M and Tognon M (1998) Simian-virus-40 footprints in human lymphoproliferative disorders of HIV– and HIV+ patients. Int J Cancer 78: 669–674

    Article  CAS  Google Scholar 

  • Mortimer EA Jr., Lepow ML, Gold E, Robbins FC, Burton GJ and Fraumeni JF Jr. (1981) Longterm follow-up of persons inadvertently inoculated with SV40 as neonates. N Engl J Med 305: 1517–1518

    Article  Google Scholar 

  • Olin P and Geisecke J (1998) Potential exposure to SV40 in polio vaccines used in Sweden during 1957: no impact on cancer incidence rates 1960 to 1993. In Brown F, Lewis AMSimian virus 40 (SV40): A possible human polyomavirus. Dev Biol Stand 94: 227–233

    CAS  Google Scholar 

  • Patterson BH and Bilgrad R (1986) Use of the National Death Index in cancer studies. J Natl Cancer Inst 77: 877–881

    CAS  PubMed  Google Scholar 

  • Rizzo P, Carbone M, Fisher SG, Matker C, Swinnen LV, Powers A, DiResta I, Alkan S, Pass HI and Fisher RI (1999) Simian virus 40 is present in most United States human mesotheliomas, but it is rarely present in non-Hodgkin’s lymphoma. Chest 116: 470S–473S

    Article  CAS  Google Scholar 

  • Shah K and Nathanson N (1976) Human exposure to SV40: review and comment. Am J Epidemiol 103: 1–12

    Article  CAS  Google Scholar 

  • Shah KV, Daniel RW, Strickler HD and Goedert JJ (1997) Investigation of human urine for genomic sequences of the primate polyomaviruses simian virus 40, BK virus, and JC virus. J Infect Dis, 1618–1621

    Article  CAS  Google Scholar 

  • Stenton SC (1998) Editorial. Simian virus 40 and human malignancy. BMJ 316: 877

    Article  CAS  Google Scholar 

  • Strickler HD and Goedert JJ (1998) Exposure to SV40-contaminated poliovirus vaccine and the risk of cancer-A review of the epidemiological evidence. Dev Biol Stand 94: 235–244

    CAS  PubMed  Google Scholar 

  • Strickler HD, Goedert JJ, Fleming M, Travis WD, Williams AE, Rabkin CS, Daniel RW and Shah KV (1996) Simian virus 40 and pleural mesothelioma in humans. Cancer Epidemiol Biomarkers Prev 5: 473–475

    CAS  PubMed  Google Scholar 

  • Strickler HD, Rosenberg PS, Devesa SS, Hertel J, Fraumeni JF Jr., and Goedert JJ (1998) Contamination of poliovirus vaccines with simian virus 40 (1955–1963) and subsequent cancer rates. JAMA 279: 292–295

    Article  CAS  Google Scholar 

  • Sweet BH and Hilleman MR (1960) The vacuolating virus, SV40. Proc Soc Exp Biol Med 105: 420–427

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mandel School of Applied Social Sciences, Case Western Reserve University, Cleveland, 44106-7164, OH, USA

    C Carroll-Pankhurst

  2. Viral Epidemiology Branch, National Cancer Institute, Rockville, 20852, MD, USA

    E A Engels, H D Strickler & J J Goedert

  3. Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, 44106-4945, OH, USA

    J Wagner & E A Mortimer Jr

Authors
  1. C Carroll-Pankhurst
    View author publications

    Search author on:PubMed Google Scholar

  2. E A Engels
    View author publications

    Search author on:PubMed Google Scholar

  3. H D Strickler
    View author publications

    Search author on:PubMed Google Scholar

  4. J J Goedert
    View author publications

    Search author on:PubMed Google Scholar

  5. J Wagner
    View author publications

    Search author on:PubMed Google Scholar

  6. E A Mortimer Jr
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/

Reprints and permissions

About this article

Cite this article

Carroll-Pankhurst, C., Engels, E., Strickler, H. et al. Thirty-five year mortality following receipt of SV40-contaminated polio vaccine during the neonatal period. Br J Cancer 85, 1295–1297 (2001). https://doi.org/10.1054/bjoc.2001.2065

Download citation

  • Received: 17 April 2001

  • Revised: 02 July 2001

  • Accepted: 24 July 2001

  • Published: 30 October 2001

  • Issue date: 02 November 2001

  • DOI: https://doi.org/10.1054/bjoc.2001.2065

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • SV40
  • poliovirus vaccines
  • cancer
  • newborns

This article is cited by

  • Mortality ascertainment of participants in the National Wilms Tumor Study using the National Death Index: comparison of active and passive follow-up results

    • Cecilia A Cotton
    • Susan Peterson
    • Norman E Breslow

    Epidemiologic Perspectives & Innovations (2007)

  • Space-time Clustering Analyses of Testicular Cancer Amongst 15–24-year-olds in Northern England

    • R. J. Q. McNally
    • M. S. Pearce
    • L. Parker

    European Journal of Epidemiology (2006)

  • Polio vaccines, Simian Virus 40, and human cancer: the epidemiologic evidence for a causal association

    • Tam Dang-Tan
    • Salaheddin M Mahmud
    • Eduardo L Franco

    Oncogene (2004)

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Current issue
  • Collections
  • Follow us on Twitter
  • Sign up for alerts
  • RSS feed

About the journal

  • Journal Information
  • Open access publishing
  • About the Editors
  • Contact
  • Special Issues
  • For Advertisers
  • Subscribe

Publish with us

  • For Authors & Referees
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

British Journal of Cancer (Br J Cancer)

ISSN 1532-1827 (online)

ISSN 0007-0920 (print)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited